<DOC>
	<DOCNO>NCT01909219</DOCNO>
	<brief_summary>This endoscopist-blinded , prospective , multicenter study involve adult outpatient aim evaluate whether sodium picosulphate/magnesium citrate split dose associate high efficacy acceptability comparison standard dose regimen bowel cleanse colonoscopy</brief_summary>
	<brief_title>PMC Split Preparation Colon Cleansing</brief_title>
	<detailed_description>Picosulphate/magnesium citrate effective , safe tolerate low-volume preparation colon cleansing . This study evaluate whether split dose associated increase efficacy acceptability comparison standard dose regimen . This multicenter , randomize , single-blind study perform 15 endoscopic service Italy . Adult outpatient undergo colonoscopy receive picosulphate/magnesium citrate either standard dosing ( group A , two sachet day endoscopy ) , split dose ( group B , second dose morning colonoscopy ) . Bowel cleanse assess use Boston Scale ( BBPS ) rat adequate &gt; 2 segment . Patient acceptance , satisfaction , relate symptom also record .</detailed_description>
	<mesh_term>Picosulfate sodium</mesh_term>
	<mesh_term>Magnesium citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>adult outpatient age 1885 yr undergo elective colonoscopy previous colon resection , ileus , intestinal obstruction , toxic megacolon , severe heart failure ( NYHA Class III IV ) , acute cardiovascular disease , uncontrolled arterial hypertension ( systolic pressure &gt; 170 mmHg , diastolic pressure &gt; 100 mmHg ) , severe liver cirrhosis ( ChildPugh score C ) , renal failure ( creatinine clearance &lt; 30 mL/minute ) , ascites , phenylketonuria , glucose6phosphate dehydrogenase deficiency , pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>preparation , cleanse , colon</keyword>
</DOC>